MedTrace Logo

The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

NCT05371756 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-03-16

No results posted yet for this study

Summary

The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and ethnic backgrounds matched with serial biospecimens over a patients journey with cancer marks the TIOB as a unique research facility.

Conditions

Sponsors & Collaborators

  • Translational Genomics Research Institute

    collaborator OTHER

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Ronan J Kelly, MD, MBA · Baylor Scott & White Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-11
Primary Completion
2035-09-11
Completion
2050-09-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05371756 on ClinicalTrials.gov